Text messaging tool may help fight opioid epidemic
A new automated text messaging service may curb opioid abuse and reduce the likelihood of relapse while also decreasing treatment costs, according to researchers at …
Epharmix’s behavioral health tools help partners engage vulnerable populations and improve outcomes
Helping patients with behavioral health issues manage their condition successfully is a top priority for most providers. While the term behavioral health refers to both mental …
Top accelerator Dreamit Health selects Epharmix to join its latest cohort
Top health accelerator, Dreamit Health recently selected Epharmix and six additional new companies to join its 2018 cohort. The new companies have developed innovative technology …
Missouri Governor Eric Greitens visits Epharmix during launch of Innovation Task Force report
Governor Greitens established the Governor’s Innovation Task Force (GITF) on June 19, 2017 to bring together private and public sector leaders from across the State in a …
Study: A novel patient engagement platform using accessible text messages and calls (Epharmix), maintains high patient engagement, collects and alerts providers to actionable health data
Health care providers managing patients with chronic disease recognize the need for long-term patient engagement strategies to improve compliance with therapy and treatments in between …
New publication finds EpxDiabetes helped patients reduce A1c by 1.15% in just 4 months
A newly published study in JMIR-Diabetes, found that our automated messaging intervention, EpxDiabetes helped lower HbA1c by 1.15% in just four months, while keeping patients engaged for the long-term, …
Announcing the inaugural event, Engage: A Healthcare Communication Conference
We hope you can join us for Engage: A Healthcare Communication Conference on Sept. 28th at Washington University School of Medicine. The Engage conference is sponsored …
New research in Nature Scientific Reports finds that automated messaging intervention, EpxDialysis, improved patient adherence to dialysis treatment by 75%
In a recently published study in Nature Scientific Reports, researchers from Washington University in St. Louis School of Medicine and Saint Louis University School of …
STL-Live interview reports impact of our partnership with mental health provider, Provident, Inc.
Sarah Thompson, the host of television show STL-Live, interviewed our CEO, Blake Marggraff, and Stephanie Lessmeier, Director of the Hope After program at Provident Inc. about …
Research proving the Epharmix medication adherence platform published in JMIR-RP
Medication adherence leads to better health outcomes and healthcare cost savings, yet patients often do not complete therapy. Every patient faces unique challenges, so the reasons …